The scientific advisory board plays an essential role in guiding our research. Our advisors are among the world’s leading experts in the physics-driven drug design process that is the foundation for our development efforts.
-
Todd Martinez, Ph.D.
Professor of Chemistry and Photon Sciences; Stanford University
-
James Rush, Ph.D.
Chief Executive Officer; Spica Therapeutics
-
Peter Tummino, Ph.D.
President, Research and Development; Nimbus Therapeutics
-
Harald Wajant, Ph.D.
Professor and Division of Molecular Internal Medicine; University Hospital of Würzburg